Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mivacurium

S Feldman1

  • 1Department of Anaesthetics, Charing Cross and Westminster Medical School, Chelsea and Westminster Hospital, London.

British Journal of Hospital Medicine
|March 5, 1997
PubMed
Summary
This summary is machine-generated.

Mivacurium, a muscle relaxant, is hydrolyzed by plasma cholinesterase like suxamethonium. Despite a slower onset and longer duration, it offers a shorter action than other non-depolarizing drugs at clinical doses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants.

The Journal of pediatrics·1997
Same author

Anaesthesia and the Research Assessment Exercise.

Anaesthesia·1997
Same author

Depressed autoantibody synthesis in Trypanosoma cruzi-infected rats born to mothers undergoing this infection during pregnancy.

Journal of reproductive immunology·1997
Same author

Neuromuscular block.

Anaesthesia and intensive care·1997
Same author

The role of private-for-profit managed behavioral health in the public sector.

Administration and policy in mental health·1997
Same author

Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle.

Brain research·1997
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Neuromuscular Blockade

Background:

  • Mivacurium is a non-depolarizing muscle relaxant introduced in 1988.
  • It shares pharmacokinetic similarities with suxamethonium, including hydrolysis by plasma cholinesterase.

Purpose of the Study:

  • To compare the pharmacokinetic and pharmacodynamic profile of mivacurium with suxamethonium and other non-depolarizing muscle relaxants.
  • To evaluate the clinical duration of action of mivacurium at standard doses.

Main Methods:

  • Pharmacokinetic analysis of mivacurium.
  • Comparison of onset and duration of action with suxamethonium and other non-depolarizing agents.
  • Clinical dose-response studies.

Main Results:

Related Experiment Videos

  • Mivacurium is hydrolyzed by plasma cholinesterase.
  • It exhibits a slower onset and longer duration of action compared to suxamethonium.
  • However, at clinically relevant doses, mivacurium's duration is shorter than alternative non-depolarizing muscle relaxants.

Conclusions:

  • Mivacurium offers a unique profile among non-depolarizing muscle relaxants.
  • Its intermediate duration of action makes it a useful alternative in certain clinical settings.
  • Plasma cholinesterase activity is a key determinant of mivacurium's duration.